FDA approves generic prostate cancer drug Casodex But It Probably Won’t be Shipping From Michigan
Posted Jul 07 2009 9:54pm
Caraco has been in the news quite a bit lately, first with the raid and then laying off 350 employees in Michigan, so now with the approval of a new generic drug for prostate cancer, odds are that it will come from another location. BD
DETROIT -- Caraco Pharmaceutical Laboratories Ltd. said Tuesday it started shipping a generic version of Casodex, a prostate cancer drug, after receiving marketing approval from the Food and Drug Administration.
The application was filed by Caraco's subsidiary Sun Pharmaceutical Laboratories ( PHLB.PK - news - people ) Ltd. Mylan Inc. of Pittsburgh also received FDA approval for a generic version of Casodex, or bicalutamide tablets, on Tuesday, and began shipping the product.